GGrantIndex
← Leaderboards

Sarah L. Berga

University Of Pittsburgh At Pittsburgh

$1,965,640
Attributed
$1,965,640
Total exposure
14
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $19.8K · FY200507
$20K$15K$10K$5K$0
'05
'06
'07

Funding mix

By agency

NIH$1,965,640 · 14

By mechanism

R01$1,318,327 · 1
U54$529,239 · 1
M01$118,074 · 12

Top collaborators

No co-investigators on record.

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Human Subject

Research focus

Human SubjectClinical ResearchFemaleWomen'S HealthHuman Therapy EvaluationAmenorrheaPostmenopauseHormone TherapyCognitive Behavior TherapyHormone Regulation /Control MechanismPathologic ProcessEstrogensEthinyl EstradiolPsychophysiologyNorethindroneAndrogen InhibitorGonadotropin Releasing FactorBehavioral /Social Science Research TagPsychological StressorPolycystic Ovary SyndromeOvulationFollicle Stimulating HormoneBehavior DisordersHormone Biosynthesis

Grant awards (42)

REGULATION OF GONADOTROPIN RELEASING HORMONE (GNRH) DRIVE IN POLYCYSTIC OVARY$133
M01 · FY2007 · RR · contact PI
GONADOTROPIN RELEASING HORMONE (GNRH) DRIVE IN PCOS$19,833
M01 · FY2006 · RR · contact PI
REGULATION OF GNRH DRIVE IN POLYCYSTIC OVARY SYNDROME$2,998
M01 · FY2005 · RR
REGULATION OF GNRH DRIVE IN POLYCYSTIC OVARY SYNDROME$263
M01 · FY2005 · RR
Regulation of GnRH Drive in Polycystic Ovary Syndrome$57,744
M01 · FY2004 · RR
Regulation of GnRH Drive in Polycystic Ovary Syndrome$16,026
M01 · FY2004 · RR
Functional Hypothalamic Amenorrhea - II$11,193
M01 · FY2004 · RR
Pathogenesis of Functional Hypothalamic Amenorrhea$3,816
M01 · FY2004 · RR
REGULATION OF GNRH DRIVE IN PCOS$176,413
U54 · FY2002 · HD
ESTRADIOL DROSPIRENONE COMB--POSTMENOPAUS ENDOMETRIUM$0
M01 · FY2002 · RR
PATHOGENESIS OF FUNCTIONAL HYPOTHALAMIC AMENORRHEA PART II$0
M01 · FY2002 · RR
PATHOGENESIS OF FUNCTIONAL HYPOTHALAMIC AMENORRHEA PART II$0
M01 · FY2002 · RR
IMPACT OF GONADAL STEROID UPON SEROTONERGIC FUNCTION$0
M01 · FY2002 · RR
IMPACT OF GONADAL STEROID UPON SEROTONERGIC FUNCTION$0
M01 · FY2002 · RR
FUNCTIONAL HYPOTHALAMIC AMENORRHEA$0
M01 · FY2002 · RR
FUNCTIONAL HYPOTHALAMIC AMENORRHEA$0
M01 · FY2002 · RR
ESTRADIOL DROSPIRENONE COMB--POSTMENOPAUS ENDOMETRIUM$0
M01 · FY2002 · RR
ORTHO TRICYCLEN ON BONE METABOLISM AMENORRHEA/OSTEOPENI$0
M01 · FY2002 · RR
ORTHO TRICYCLEN ON BONE METABOLISM AMENORRHEA/OSTEOPENI$0
M01 · FY2002 · RR
NORETHINDRONE WITH ETHINYL ESTRADIOL IN PERIMENOPAUSE$0
M01 · FY2002 · RR
NORETHINDRONE WITH ETHINYL ESTRADIOL IN PERIMENOPAUSE$0
M01 · FY2002 · RR
COMP TRIAL OF FEMHRT, EVISTA AND PREMPRO IN POSTMENOPAUS$0
M01 · FY2002 · RR
COMP TRIAL OF FEMHRT, EVISTA AND PREMPRO IN POSTMENOPAUS$0
M01 · FY2002 · RR
PATHOGENESIS OF FUNCTIONAL HYPOTHALAMIC AMENORRHEA$633,588
R01 · FY2001 · MH
REGULATION OF GNRH DRIVE IN PCOS$176,413
U54 · FY2001 · HD
ESTRADIOL DROSPIRENONE COMB--POSTMENOPAUS ENDOMETRIUM$0
M01 · FY2001 · RR
ORTHO TRICYCLEN ON BONE METABOLISM AMENORRHEA/OSTEOPENI$0
M01 · FY2001 · RR
COMP TRIAL OF FEMHRT, EVISTA AND PREMPRO IN POSTMENOPAUS$0
M01 · FY2001 · RR
NORETHINDRONE WITH ETHINYL ESTRADIOL IN PERIMENOPAUSE$0
M01 · FY2001 · RR
PATHOGENESIS OF FUNCTIONAL HYPOTHALAMIC AMENORRHEA PART II$0
M01 · FY2001 · RR
IMPACT OF GONADAL STEROID UPON SEROTONERGIC FUNCTION$0
M01 · FY2001 · RR
FUNCTIONAL HYPOTHALAMIC AMENORRHEA$0
M01 · FY2001 · RR
PATHOGENESIS OF FUNCTIONAL HYPOTHALAMIC AMENORRHEA$684,739
R01 · FY2000 · MH
REGULATION OF GNRH DRIVE IN PCOS$176,413
U54 · FY2000 · HD
PATHOGENESIS OF FUNCTIONAL HYPOTHALAMIC AMENORRHEA PART I$3,034
M01 · FY2000 · RR
PATHOGENESIS OF FUNCTIONAL HYPOTHALAMIC AMENORRHEA PART II$3,034
M01 · FY2000 · RR
COMP TRIAL OF FEMHRT, EVISTA AND PREMPRO IN POSTMENOPAUS$0
M01 · FY2000 · RR
ORTHO TRICYCLEN ON BONE METABOLISM AMENORRHEA/OSTEOPENI$0
M01 · FY2000 · RR
FUNCTIONAL HYPOTHALAMIC AMENORRHEA$0
M01 · FY2000 · RR
IMPACT OF GONADAL STEROID UPON SEROTONERGIC FUNCTION$0
M01 · FY2000 · RR
ESTRADIOL DROSPIRENONE COMB--POSTMENOPAUS ENDOMETRIUM$0
M01 · FY2000 · RR
NORETHINDRONE WITH ETHINYL ESTRADIOL IN PERIMENOPAUSE$0
M01 · FY2000 · RR